Science | 18 May 2022 | News
India lags behind other nations in actively promoting science: Study
Research communication attracts funders, increases opportunities for multi-institutional collaborations and mu...Read more
Opinion | 17 May 2022 | Views
Growth of therapeutic respiratory devices market in India
Breathing difficulties are an issue that affects millions of people every day, all around the world. It might ...Read more
Special | 30 April 2022 | Features
Indian biopharma industry hits Rs 33k crore with 13% growth in 2020-21
Amidst the pandemic, the Indian Biopharma Industry, with over 300 companies, has witnessed a good growth of 13...Read more
Start-ups | 18 May 2022 | News
Guwahati Biotech Park & IIT-G announce ASSAM BIOTECH CONCLAVE 2022
A state-of-the-art Technology Incubator Centre (TIC) with an incubation space of 1,00,000 sq ft has been ...Read more
Supplier | 17 May 2022 | News
PerkinElmer expands genomic testing services with urWGS
PerkinElmer has announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer G...Read more
People | 19 May 2022 | News
Dr Nina Kottler joins Synapsica’s Advisory Board
Dr Nina Kottler, Associate Chief Medical Officer for Clinical Artificial Intelligence at Radiology Partners, h...Read more
Academics | 21 May 2022 | News
MedLern, BMJ Publishing Group launch CPD courses for Indian nurses
MedLern and BMJ Publishing Group (British Medical Journal publishing group) have teamed up to provide via its ...Read more
Blogs | 08 May 2022 | Views
Returning Mothers: Upskilling Their Way in Their Career
Whether you are a mother who has been out of the workplace for one year or ten years, the thought of restartin...Read more
Amidst the pandemic, the Indian Biopharma Industry, with over 300 companies, has witnessed a good growth of 13 percent, 2 percent less than the previous year’s 15 percent growth rate. This growth was largely driven by the performance of the Indian biopharma companies which have done very well as against multinational companies. As a result, the Indian Biopharma Industry has crossed the Rs 33,000 crore mark for the year 2020-21 over the previous year’s figure of Rs 29,176 crore. The Indian Biopharma industry, comprising hormones, insulin, blood products, and vaccines recorded a sales revenue of Rs 33,067 crore for the year 2020-21.